Abstract
Human sirtuin 2 (SIRT2) is an attractive target molecule for development of drugs to treat neurodegenerative diseases and cancer, because SIRT2 inhibitors have a protective effect against neurodegeneration and an anti-proliferative effect on cancer stem cells. We designed and synthesized a series of benzamide derivatives as SIRT2 inhibitor candidates. Among them, compound 17k showed the most potent SIRT2-inhibitory activity (IC50=0.60μM), with more than 150-fold selectivity over SIRT1 and SIRT3 isoforms (IC50 >100μM).
Keywords:
SIRT2; Sirtuin.
Copyright © 2014 Elsevier Ltd. All rights reserved.
MeSH terms
-
Benzamides / chemical synthesis
-
Benzamides / chemistry*
-
Benzamides / metabolism
-
Binding Sites
-
Drug Design*
-
Histone Deacetylase Inhibitors / chemical synthesis*
-
Histone Deacetylase Inhibitors / chemistry
-
Histone Deacetylase Inhibitors / metabolism
-
Humans
-
Molecular Docking Simulation
-
Protein Binding
-
Protein Structure, Tertiary
-
Recombinant Proteins / biosynthesis
-
Recombinant Proteins / chemistry
-
Recombinant Proteins / genetics
-
Sirtuin 1 / antagonists & inhibitors
-
Sirtuin 1 / metabolism
-
Sirtuin 2 / antagonists & inhibitors*
-
Sirtuin 2 / genetics
-
Sirtuin 2 / metabolism
-
Sirtuin 3 / antagonists & inhibitors
-
Sirtuin 3 / metabolism
-
Structure-Activity Relationship
Substances
-
Benzamides
-
Histone Deacetylase Inhibitors
-
Recombinant Proteins
-
benzamide
-
Sirtuin 1
-
Sirtuin 2
-
Sirtuin 3